
Hisham Mohamed Abdel-Azim MD
Assistant Professor, Pediatrics, USC School of Medicine
Join to view full profile
4650 W Sunset BlvdMs# 62Los Angeles, CA 90027
Phone+1 323-669-4559
Fax+1 323-660-1904
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hisham Abdel-Azim, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California and Maine. He is an Assistant Professor at USC School of Medicine.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Westchester Medical CenterResidency, Pediatrics, 2000 - 2002
Ain Shams University Faculty of MedicineClass of 2000
Cairo University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2002 - 2028
ME State Medical License Active through 2020
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 3 citationsExploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia...Yi Xu, Shengwen Calvin Li, Jeffrey Xiao, Qian Liu, Durga Cherukuri
Drug Resistance Updates. 2025-03-01 - 8 citationsEffect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.Christopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, Hisham Abdel-Azim, Alice Bertaina
Blood Advances. 2024-12-10 - 5 citationsDevelopment of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.Huynh Cao, Jeffrey Xiao, David J Baylink, Vinh Nguyen, Nathan Shim
Biomedicines. 2024-10-03
Press Mentions
TBI-Free Conditioning Before Transplant Effective in MRD-Negative B-ALLDecember 7th, 2025
‘Practice-Changing’ Findings May Spare Some Young Patients with Leukemia from RadiationDecember 6th, 2025
Advances in Technology Help Improve Safety and Access to Blood Cancer TherapiesDecember 6th, 2025









